Recently Dr. Anthony Fauci was on CNN when Dr. Sanjay Gupta asked him about a study TrialSite covered out of Israel that found natural immunity to SARS-CoV-2 infection was essentially better than the immunity associated with the COVID-19 vaccines. Gupta asked the nation’s top doctor—a veritable treasure trove of knowledge on all things COVID-19—what he thought about this topic, given Gupta gets lots of calls asking him about this topic. Fauci, in response, sort of fumbled, paused and declared, “You know, that’s a really good point, Sanjay. I don’t have a really firm answer for you on that. That’s something that we're going to have to discuss regarding the durability of the response.”
Dr. Fauci knows more, of course, then he lets on. He, or more likely his subordinates, are undoubtedly picking apart these studies and raising the specter of durability, that is, how “durable” or long-lasting an immune response is, a crucial characteristic of highly effective vaccines as well as natural immune response.
Now studies are indicating that the Pfizer-BioNTech mRNA vaccine has some challenges on the durable front—at least when it comes to the delta variant as studies indicate the vac...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).